{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["(\u2212)-Guaiol", "MHY1485", "NSCLC", "autophagy", "cell survival", "mTORC1", "mTORC2"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29611762", "DateCompleted": {"Year": "2019", "Month": "08", "Day": "13"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "04", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10.1080/15384047.2018.1451277"], "Journal": {"ISSN": "1555-8576", "JournalIssue": {"Volume": "19", "Issue": "8", "PubDate": {"Year": "2018", "Month": "Aug", "Day": "03"}}, "Title": "Cancer biology & therapy", "ISOAbbreviation": "Cancer Biol Ther"}, "ArticleTitle": "(-)-Guaiol regulates autophagic cell death depending on mTOR signaling in NSCLC.", "Pagination": {"StartPage": "706", "EndPage": "714", "MedlinePgn": "706-714"}, "Abstract": {"AbstractText": ["(-)-Guaiol, a sesquiterpene alcohol with the guaiane skeleton, has been found in many Chinese medicinal plants and been reported to comprise various guaiane natural products that are well known for their antibacterial activities. Previously, we have shown its antitumor activity by inducing autophagy in NSCLC cells. However, its potential mechanism in inducing autophagy is still under our investigation. Here, data from our western blotting assays showed that, in NSCLC cells, (-)-Guaiol significantly blocked the mTORC2-AKT signaling by suppressing mTOR phosphorylation at serine 2481 (S2481) to induce autophagy, illustrated by the increasing ratio of LC3II/I. Besides, it impaired the mTORC1 signaling by inhibiting the activity of its downstream factors, such as 4E-BP1 and p70 S6K, all of which could obviously rescued by the mTOR activator MHY1485. Afterwards, results from biofunctional assays, including cell survival analysis, colony formation assays and flow cytometry assays, suggested that (-)-Guaiol triggered autophagic cell death by targeting both mTORC1 and mTORC2 signaling pathways. In summary, our studies showed that (-)-Guaiol inhibited the proliferation of NSCLC cells by specifically targeting mTOR signaling pathways, including both mTORC1 and mTORC2 signaling, providing a better therapeutic option for substituting rapamycin in treating NSCLC patients."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Department of oncology , Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine , Shanghai , China."}], "LastName": "Yang", "ForeName": "Xiaohui", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "c Department of laboratory medicine , Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine , Shanghai , China."}], "LastName": "Zhu", "ForeName": "Jiabei", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Department of oncology , Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine , Shanghai , China."}], "LastName": "Wu", "ForeName": "Jianchun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Clinical Laboratory Medicine , Tenth People's Hospital of Tongji University , Shanghai , China."}], "LastName": "Huang", "ForeName": "Nan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Clinical Laboratory Medicine , Tenth People's Hospital of Tongji University , Shanghai , China."}], "LastName": "Cui", "ForeName": "Zhongqi", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Department of oncology , Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine , Shanghai , China."}], "LastName": "Luo", "ForeName": "Yingbin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Clinical Laboratory Medicine , Tenth People's Hospital of Tongji University , Shanghai , China."}], "LastName": "Sun", "ForeName": "Fenyong", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "c Department of laboratory medicine , Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine , Shanghai , China."}], "LastName": "Pan", "ForeName": "Qiuhui", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Department of oncology , Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine , Shanghai , China."}], "LastName": "Li", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Clinical Laboratory Medicine , Tenth People's Hospital of Tongji University , Shanghai , China."}], "LastName": "Yang", "ForeName": "Qingyuan", "Initials": "Q"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Cancer Biol Ther", "NlmUniqueID": "101137842", "ISSNLinking": "1538-4047"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes, Guaiane"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Mechanistic Target of Rapamycin Complex 2"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}, {"RegistryNumber": "I7WP008A91", "NameOfSubstance": "guaiol"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Autophagy"}, {"QualifierName": ["metabolism"], "DescriptorName": "Carcinoma, Non-Small-Cell Lung"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Mechanistic Target of Rapamycin Complex 2"}, {"QualifierName": [], "DescriptorName": "Models, Biological"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": [], "DescriptorName": "Sesquiterpenes, Guaiane"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "TOR Serine-Threonine Kinases"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Choudhary MI, Batool I, Atif M, Hussain S, Atta-Ur Rahman. Microbial transformation of (\u2212)-guaiol and antibacterial activity of its transformed products. J Nat Prod. 2007;70(5):849-52. doi:10.1021/np068052a.", "ArticleIdList": ["10.1021/np068052a", "17385913"]}, {"Citation": "Yang Q, Wu J, Luo Y, Huang N, Zhen N, Zhou Y, Sun F, Li Z, Pan Q, Li Y. (\u2212)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer. Oncotarget. 2016;7(38):62585\u201362597. doi:10.18632/oncotarget.11540.", "ArticleIdList": ["10.18632/oncotarget.11540", "PMC5308748", "27566579"]}, {"Citation": "Kim N, Jeong S, Jing K, Shin S, Kim S, Heo JY, Kweon GR, Park SK, Wu T, Park JI, et\u00a0al.. Docosahexaenoic acid induces cell death in human non-small cell lung cancer cells by repressing mTOR via AMPK activation and PI3K/Akt inhibition. Biomed Res Int. 2015;2015:239764.", "ArticleIdList": ["PMC4538321", "26339598"]}, {"Citation": "Chen M, Du Y, Qui M, Wang M, Chen K, Huang Z, Jiang M, Xiong F, Chen J, Zhou J, et\u00a0al.. Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway. Oncol Rep. 2013;29(2):430\u20136. doi:10.3892/or.2012.2131.", "ArticleIdList": ["10.3892/or.2012.2131", "PMC3583607", "23151908"]}, {"Citation": "Li YC, He SM, He ZX, Li M, Yang Y, Pang JX, Zhang X, Chow K, Zhou Q, Duan W, Zhou ZW, Yang T, Huang GH, et\u00a0al.. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. Cancer Lett. 2014;344(2):239\u201359. doi:10.1016/j.canlet.2013.11.001.", "ArticleIdList": ["10.1016/j.canlet.2013.11.001", "24280585"]}, {"Citation": "Han D, Li SJ, Zhu YT, Liu L, Li MX. LKB1/AMPK/mTOR signaling pathway in non-small-cell lung cancer. Asian Pac J Cancer Prev. 2013;14(7):4033\u20139. doi:10.7314/APJCP.2013.14.7.4033.", "ArticleIdList": ["10.7314/APJCP.2013.14.7.4033", "23991948"]}, {"Citation": "Jhanwar-Uniyal M, Gillick JL, Neil J, Tobias M, Thwing ZE, Murali R. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes. Adv Biol Regul. 2015;57:64\u201374. doi:10.1016/j.jbior.2014.09.004.", "ArticleIdList": ["10.1016/j.jbior.2014.09.004", "25442674"]}, {"Citation": "Sekuli\u0107 A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, Abraham RT. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 2000;60(13):3504\u201313.", "ArticleIdList": ["10910062"]}, {"Citation": "Copp J, Manning G, Hunter T. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 2009;69(5):1821\u20137. doi:10.1158/0008-5472.CAN-08-3014.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-3014", "PMC2652681", "19244117"]}, {"Citation": "Chen BW, Chen W, Liang H, Liu H, Liang C, Zhi X, Hu LQ, Yu XZ, Wei T, Ma T, et\u00a0al.. Inhibition of mTORC2 induces cell-cycle arrest and enhances the cytotoxicity of doxorubicin by suppressing MDR1 expression in HCC cells. Mol Cancer Ther. 2015;14(8):1805\u201315. doi:10.1158/1535-7163.MCT-15-0029.", "ArticleIdList": ["10.1158/1535-7163.MCT-15-0029", "PMC4866512", "26026051"]}, {"Citation": "Cargnello M, Tcherkezian J, Roux PP. The expanding role of mTOR in cancer cell growth and proliferation. Mutagenesis. 2015;30(2):169\u201376. doi:10.1093/mutage/geu045.", "ArticleIdList": ["10.1093/mutage/geu045", "PMC5943824", "25688110"]}, {"Citation": "Pause A, Belsham GJ, Gingras AC, Donz\u00e9 O, Lin TA, Lawrence JC Jr, Sonenberg N. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5\u2032-cap function. Nature. 1994;371(6500):762\u20137. doi:10.1038/371762a0.", "ArticleIdList": ["10.1038/371762a0", "7935836"]}, {"Citation": "Huo HZ, Zhou ZY, Wang B, Qin J, Liu WY, Gu Y. Dramatic suppression of colorectal cancer cell growth by the dual mTORC1 and mTORC2 inhibitor AZD-2014. Biochem Biophys Res Commun. 2014;443(2):406\u201312. doi:10.1016/j.bbrc.2013.11.099.", "ArticleIdList": ["10.1016/j.bbrc.2013.11.099", "24309100"]}, {"Citation": "Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, G\u00e9linas C, Fan Y, et\u00a0al.. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 2006;10(1):p. 51. doi:10.1016/j.ccr.2006.06.001.", "ArticleIdList": ["10.1016/j.ccr.2006.06.001", "PMC2857533", "16843265"]}, {"Citation": "Shang L, Chen S, Du F, Li S, Zhao L, Wang X. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci U S A. 2011;108(12):4788\u201393. doi:10.1073/pnas.1100844108.", "ArticleIdList": ["10.1073/pnas.1100844108", "PMC3064373", "21383122"]}, {"Citation": "Ji J, Zheng PS. Activation of mTOR signaling pathway contributes to survival of cervical cancer cells. Gynecol Oncol. 2010;117(1):103\u20138. doi:10.1016/j.ygyno.2009.12.020.", "ArticleIdList": ["10.1016/j.ygyno.2009.12.020", "20102778"]}, {"Citation": "Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov. 2006;5(8):671\u201388. doi:10.1038/nrd2062.", "ArticleIdList": ["10.1038/nrd2062", "16883305"]}, {"Citation": "Strimpakos AS, Karapanagiotou EM, Saif MW, Syrigos KN. The role of mTOR in the management of solid tumors: an overview. Cancer Treat Rev. 2009;35(2):148\u201359. doi:10.1016/j.ctrv.2008.09.006.", "ArticleIdList": ["10.1016/j.ctrv.2008.09.006", "19013721"]}, {"Citation": "Punt CJ, Boni J, Bruntsch U, Peters M, Thielert C. Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors. Ann Oncol. 2003;14(6):931\u20137. doi:10.1093/annonc/mdg248.", "ArticleIdList": ["10.1093/annonc/mdg248", "12796032"]}, {"Citation": "Zhang YJ, Duan Y, Zheng XF. Targeting the mTOR kinase domain: the second generation of mTOR inhibitors. Drug Discov Today. 2011;16(7\u20138):325\u201331. doi:10.1016/j.drudis.2011.02.008.", "ArticleIdList": ["10.1016/j.drudis.2011.02.008", "PMC3073023", "21333749"]}, {"Citation": "Schalm SS, Blenis J. Identification of a conserved motif required for mTOR signaling. Curr Biol. 2002;12(8):632\u20139. doi:10.1016/S0960-9822(02)00762-5.", "ArticleIdList": ["10.1016/S0960-9822(02)00762-5", "11967149"]}, {"Citation": "Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 2004;14(14):1296\u2013302.", "ArticleIdList": ["15268862"]}, {"Citation": "Xu Y, Liu C, Chen S, Ye Y, Guo M, Ren Q, Liu L, Zhang H, Xu C, Zhou Q, et\u00a0al.. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease. Cell Signal. 2014;26(8):1680\u20139. doi:10.1016/j.cellsig.2014.04.009.", "ArticleIdList": ["10.1016/j.cellsig.2014.04.009", "PMC4039615", "24726895"]}, {"Citation": "Choi YJ, Park YJ, Park JY, Jeong HO, Kim DH, Ha YM, Kim JM, Song YM, Heo HS, Yu BP, et\u00a0al.. Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion. PLoS One. 2012;7(8):p. e43418. doi:10.1371/journal.pone.0043418.", "ArticleIdList": ["10.1371/journal.pone.0043418", "PMC3425474", "22927967"]}, {"Citation": "Zhou J, Tan SH, Nicolas V, Bauvy C, Yang ND, Zhang J, Xue Y, Codogno P, Shen HM. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion. Cell Res. 2013;23(4):508\u201323. doi:10.1038/cr.2013.11.", "ArticleIdList": ["10.1038/cr.2013.11", "PMC3616426", "23337583"]}, {"Citation": "Yang C, Peng J, Jiang W, Zhang Y, Chen X, Wu X, Zhu Y, Zhang H, Chen J, Wang J, Cho WC, et\u00a0al.. mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo. Cancer Lett. 2013;341(2):186\u201394. doi:10.1016/j.canlet.2013.08.004.", "ArticleIdList": ["10.1016/j.canlet.2013.08.004", "23933173"]}, {"Citation": "Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307(5712):1098\u2013101. doi:10.1126/science.1106148.", "ArticleIdList": ["10.1126/science.1106148", "15718470"]}, {"Citation": "Rajasekhar VK, Viale A, Socci ND, Wiedmann M, Hu X, Holland EC. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol Cell. 2003;12(4):889\u2013901. doi:10.1016/S1097-2765(03)00395-2.", "ArticleIdList": ["10.1016/S1097-2765(03)00395-2", "14580340"]}, {"Citation": "Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, Carr SA, Sabatini DM. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell. 2007;25(6):903\u201315. doi:10.1016/j.molcel.2007.03.003.", "ArticleIdList": ["10.1016/j.molcel.2007.03.003", "17386266"]}, {"Citation": "Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, Sabatini DM. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell. 2006;11(6):859\u201371. doi:10.1016/j.devcel.2006.10.007.", "ArticleIdList": ["10.1016/j.devcel.2006.10.007", "17141160"]}, {"Citation": "Liu G, Pei F, Yang F, Li L, Amin AD, Liu S, Buchan JR, Cho WC. Role of autophagy and apoptosis in non-small-cell lung cancer. Int J Mol Sci. 2017;18(2).", "ArticleIdList": ["PMC5343902", "28208579"]}, {"Citation": "Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell. 2006;22(2):159\u201368. doi:10.1016/j.molcel.2006.03.029.", "ArticleIdList": ["10.1016/j.molcel.2006.03.029", "16603397"]}, {"Citation": "Chen Y, Wei H, Liu F, Guan JL. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling. J Biol Chem. 2014;289(2):1164\u201373. doi:10.1074/jbc.M113.526335.", "ArticleIdList": ["10.1074/jbc.M113.526335", "PMC3887183", "24275666"]}, {"Citation": "Polivka J Jr, Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther. 2014;142(2):164\u201375.", "ArticleIdList": ["24333502"]}, {"Citation": "Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Gr\u00fcnwald V, Thompson JA, Figlin RA, Hollaender N, et\u00a0al.. Efficacy of everolimus in advanced renal cell carcinoma: A double-blind, randomised, placebo-controlled phase III trial. Lancet. 2008;372(9637):449\u201356. doi:10.1016/S0140-6736(08)61039-9.", "ArticleIdList": ["10.1016/S0140-6736(08)61039-9", "18653228"]}, {"Citation": "Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, et\u00a0al.. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364(6):514\u201323. doi:10.1056/NEJMoa1009290.", "ArticleIdList": ["10.1056/NEJMoa1009290", "PMC4208619", "21306238"]}]}], "History": [{"Year": "2018", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "19"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29611762", "PMC6067839", "10.1080/15384047.2018.1451277"]}}]}